AMED Insider Trading

Insider Ownership Percentage: 2.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Amedisys Insider Trading History Chart

This chart shows the insider buying and selling history at Amedisys by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

Amedisys Share Price & Price History

Current Price: $94.69
Price Change: Price Increase of +0.19 (0.20%)
As of 04/28/2025 05:00 PM ET

This chart shows the closing price history over time for AMED up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$94.69Closing price on 04/28/25:

Amedisys Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Amedisys (NASDAQ:AMED)

94.36% of Amedisys stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AMED by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$20Mbought$460ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500M$0$500MTotal InflowsTotal Outflows
Amedisys logo
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Read More on Amedisys

Today's Range

Now: $94.69
Low: $94.05
High: $94.79

50 Day Range

MA: $92.25
Low: $90.43
High: $94.69

52 Week Range

Now: $94.69
Low: $82.15
High: $98.95

Volume

295,185 shs

Average Volume

404,561 shs

Market Capitalization

$3.11 billion

P/E Ratio

37.58

Dividend Yield

N/A

Beta

0.89

Who are the major institutional investors of Amedisys?

Amedisys' top institutional investors include:
  1. CIBRA Capital Ltd — 0.66%
  2. Principal Financial Group Inc. — 0.23%
  3. SG Americas Securities LLC — 0.17%
  4. Bridge City Capital LLC — 0.11%
  5. New York State Teachers Retirement System — 0.08%
  6. Amalgamated Bank — 0.05%
Learn More about top institutional investors of Amedisys stock.

Which major investors are selling Amedisys stock?

In the last quarter, AMED stock was sold by these institutional investors:
  1. Cannon Global Investment Management LLC
  2. New York State Teachers Retirement System
  3. SG Americas Securities LLC
  4. Amalgamated Bank
  5. Yousif Capital Management LLC
  6. KBC Group NV

Which major investors are buying Amedisys stock?

Within the last quarter, AMED stock was acquired by institutional investors including:
  1. CIBRA Capital Ltd
  2. Wealthquest Corp
  3. Teacher Retirement System of Texas
  4. Parallel Advisors LLC
  5. FNY Investment Advisers LLC
  6. GAMMA Investing LLC
  7. Versant Capital Management Inc
  8. Exchange Traded Concepts LLC